SCCO Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency RCKT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Clinical Progress CCAP Q1 2026 Earnings Slight EPS Miss Amidst Stable Portfolio Performance PRH Q1 2026 Earnings Strong EPS Surge of 1539 on Solid Operational Performance TEX Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher POWI Q1 2026 Earnings EPS Surpasses Expectations Amidst Cautious Market Outlook